Birgit Bergmann

Birgit Bergmann is a Researcher at the Department of Microbiology, University of Würzburg. She co-developed the JMU-SalVac platform technology, focusing on Salmonella-based vaccines for infectious diseases and cancer therapy. Her work spans translational research, regulatory preclinical studies, and industry collaborations.

• Role: Co-leader of vaccine research group
• Expertise: Vaccine development, bacterial carrier systems, molecular genetics
• Collaborations: Pharmaceutical industry partners

Her research integrates applied microbiology with immunotherapy, targeting pathogens like SARS-CoV-2 and cancer through live attenuated bacterial vectors. She also contributes business acumen via European Business Competence Licences A/B.

Key team members collaborating with her include Heike Czotscher (microbiological work, vaccine strain production), Andrea Fick (molecular biology, ELISAs), and Lea Fink (immunization studies with Salmonella vaccines).